15th Call of Innovative Medicines Initiative – IMI2 (Pre-announcement)

Topics under consideration:

  • Integrated research platforms enabling patient-centric drug development
  • Blockchain enabled healthcare
  • Microenvironment imposed signatures in tissue and liquid biopsies in immune mediated disease
  • Emerging translational safety technologies and tools interrogating for human immunobiology
  • Development and validation of translational platforms in support of synaptopathy drug discovery
  • Digital transformation of clinical trials endpoints

Entidad Financiadora: European Comission

Plazo de Presentación: 24/10/2018

Volver al Listado